[Pe-071] English Poster Session 071「Neurogenetics, Gene therapy, and iPS cell 4」

[Pe-071-7] Establishment of an axonopathy iPSC cohort for disease modeling and drug discovery

Takeshi Niki^1,2, Keiko Imamura^1,2,3, Mika Suga^1,2, Ryo Ohara⁴, Fukiko Morii⁴, Masanori Nakagawa⁴, Mitsuya Morita⁵, Takayasu Mishima⁶, Yoshio Tsuboi⁶, Yuishin Izumi⁷, Haruhisa Inoue^1,2,3 (1.iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center (BRC), Japan, 2.Center for iPS Cells for Research and Application (CiRA), Kyoto University, Japan, 3.Medical-risk Avoidance based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP), Japan, 4.Department of Neurology, Kyoto Prefectural University of Medicine, Japan, 5.Division of Neurology, Department of Internal Medicine, Jichi Medical University Hospital, Japan, 6.Department of Neurology, Fukuoka University School of Medicine, Japan, 7.Department of Neurology, Tokushima University Graduate School of Biomedical Sciences, Japan)